GlaxoSmithKline

Glaxo (gsk), Vir Seek Eua For Intramuscular Sotrovimab In Us

GlaxoSmithKline GSK and Vir Biotechnology VIR recently announced the submission of a regulatory application to the FDA seeking emergency use authorization for intramuscular (“IM”) administration of their antibody COVID-19 drug candidate,...
Related topics: Biotechnology, Food And Drug Administration

Read More →

Us Orders 600k Doses Of Antibody Treatment To Help Fight Omicron

The U.S. is buying another 600,000 doses of a monoclonal antibody treatment from GlaxoSmithKline and Vir Biotechnology, the companies said, as the Biden administration looks to bolster treatment options.The GSK and Vir antibody treatment is the...
Related topics: Biotechnology, Joe Biden

Read More →

Former Glaxosmithkline Scientist Pleads Guilty To Stealing Trade Secrets For Chinese Pharma

Stolen information focused on monoclonal antibodies and its worth was estimated at $2 billion. The post Former GlaxoSmithKline Scientist Pleads Guilty to Stealing Trade Secrets for Chinese Pharma first appeared on Le·gal In·sur·rec·tion.

Read More →

First Plant-based Coronavirus Vaccine Shows ‘positive’ Results, Say Glaxosmithkline And Medicago

Medicago said it would file the adjuvanted plant-based coronavirus vaccine for regulatory approval with Health Canada, the FDA and others.
Related topics: Vaccines, Food And Drug Administration

Read More →

Glaxosmithkline Says Its Antibody Drug Works Against All Omicron Mutations In Lab Studies

Registered nurse prepares to treat coronavirus patient with antibody drug.Craig F. Walker/The Boston Globe/Getty Images GlaxoSmithKline said that its antibody drug worked against all Omicron mutations. The company tested the drug, called sotrovimab,...
Related topics: Genetics, Nursing

Read More →

Glaxo (gsk), Vir Covid Drug Appears Effective Against Omicron

GlaxoSmithKline GSK and Vir Biotechnology VIR announced pre-clinical data, which demonstrated that their COVID-19 therapy, sotrovimab, maintains activity against key mutations in the spike protein of the new variant of concern, Omicron. The antibody...
Related topics: Biotechnology, Genetics, Proteins

Read More →

Glaxo (gsk), Vir Intramuscular Sotrovimab Meets Study Endpoint

GlaxoSmithKline GSK and partner Vir Biotech VIR announced positive top-line data from a phase III study — COMET-TAIL — evaluating the intramuscular administration of their COVID-19 therapy candidate, sotrovimab. Data from the study...
Related topics: Medical Research

Read More →

The Us Had A Lyme Disease Vaccine Decades Ago - But The Cdc, Lawsuits, And Conspiracy Theories...

Black-legged ticks, also known as deer ticks, can transmit Lyme disease. Photon Illustration/Stocktrek Images/Getty Images Since 1998, confirmed Lyme disease cases in the US have risen roughly 40%. GlaxoSmithKline developed a Lyme vaccine in the...
Related topics: Centers For Disease Control And Prevention, Vaccines, Lawsuits, Conspiracy Theories

Read More →

Glaxo (gsk) Beats Earnings And Revenues Estimates In Q3

GlaxoSmithKline plc GSK one of the largest health care companies, reshaped its business following the March 2015 completion of the three-part, inter-conditional transaction with Novartis related to its Consumer Healthcare, Vaccines and Oncology...
Related topics: Novartis, Vaccines, Cancer, Oncology

Read More →

Here's Why 2022 Could Be A Huge Year For Glaxosmithkline

Since the first report of AIDS in 1981, the scientific community has been working tirelessly to develop therapies for AIDS, as well as preventative treatments for the initial stages, HIV.HIV specialist ViiV Healthcare is majority-owned by...
Related topics: AIDS, HIV, Virus

Read More →

Therapeutic Malaria Treatment Shown To Be 100% Effective In Phase 2 Trial

The fight against one of the world’s deadliest infectious diseases — malaria — may soon have two new weapons. The World Health Organization this week endorsed a vaccine, Mosquirix, made by British pharmaceutical company GlaxoSmithKline, that...
Related topics: Malaria, Vaccines

Read More →

Glaxo (gsk) Eyes Nod For Triumeq Expanded Use In Pediatric Hiv

GlaxoSmithKline’s GSK HIV subsidiary, ViiV Healthcare announced that a regulatory application has been filed with the FDA to seek approval for expanded use of its HIV drug Triumeq in younger children with HIV.Glaxo’s regulatory...
Related topics: HIV, Virus, Food And Drug Administration

Read More →

Florida Gov. Ron Desantis Seeks To Bypass Biden Hhs & Buy Monoclonals Directly From Drug-makers

DeSantis evaluating Eli Lilly, GlaxoSmithKline treatment options. The post Florida Gov. Ron DeSantis Seeks to Bypass Biden HHS & Buy Monoclonals Directly from Drug-Makers first appeared on Le·gal In·sur·rec·tion.
Related topics: Joe Biden

Read More →

Glaxo (gsk) Beats Earnings And Revenues Estimates In Q2

GlaxoSmithKline plc GSK one of the largest health care companies, reshaped its business following the March 2015 completion of the three-part, inter-conditional transaction with Novartis related to its Consumer Healthcare, Vaccines and Oncology...
Related topics: Novartis, Vaccines, Cancer, Oncology

Read More →

Shingrix Ok'd For Immunocompromised Adults

(MedPage Today) -- FDA expanded the approval of Shingrix, an adjuvanted recombinant zoster vaccine, for adults at increased risk of shingles due to immunosuppression, manufacturer GlaxoSmithKline (GSK) announced on Monday. The expanded indication...
Related topics: Food And Drug Administration, Vaccines

Read More →

Merck's (mrk) Keytruda Gets Fda Nod For Advanced Skin Cancer

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GlaxoSmithKline plc (GSK): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock...
Related topics: Merck & Co, Food And Drug Administration, Skin Cancer, Cancer, Oncology, Medical Research, Pfizer

Read More →

Is A Bigger Shake-up At Glaxosmithkline On The Way?

GlaxoSmithKline (NYSE: GSK) has confirmed plans to separate its consumer and pharmaceutical business units. However, an activist investor appears to want the big drugmaker to take more drastic actions. In this Motley Fool Live video recorded on June...
Related topics: Activism, Health Videos

Read More →

Glaxosmithkline's And Vir's Latest Covid Therapy Results: What Investors Should Know

GlaxoSmithKline (NYSE: GSK) and Vir Biotechnology (NASDAQ: VIR) recently reported results from a confirmatory study evaluating antibody therapy sotrovimab in treating non-hospitalized COVID-19 patients. In this Motley Fool Live video recorded on...
Related topics: Biotechnology, Nasdaq, Medical Research, Health Videos

Read More →

Sanofi (sny)/translate Bio Begin Study On Mrna Flu Vaccine

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sanofi (SNY): Free Stock Analysis Report GlaxoSmithKline plc (GSK): Free Stock...
Related topics: Sanofi, Medical Research, Flu, Influenza Vaccine, Influenza (Flu), Vaccines

Read More →

Sanofi (sny) Stops Venglustat Development As Kidney Cyst Drug

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sanofi (SNY): Free Stock Analysis Report GlaxoSmithKline plc (GSK): Free Stock...
Related topics: Sanofi, Medical Research

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.